- Home
- / Daiichi Sankyo
Daiichi Sankyo
Revenue
¥2.1 T
FY, 2026
Daiichi Sankyo Summary
Company Summary
- Overview
- Daiichi Sankyo is a pharmaceutical company. It offers medicines for cardiovascular, oncology, and more.
- Type
- Public
- Status
- Active
- HQ
- München, DE | view all locations
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
1 location detected
München, BY HQ
Germany
Zielstattstraße 48
Daiichi Sankyo Financials
Summary Financials
- Revenue (FY, 2026)
- ¥2.1T
- Gross profit (FY, 2026)
- ¥1.6T
- Net income (FY, 2026)
- ¥259.9B
- Cash (FY, 2026)
- ¥449.8B
- EBIT (FY, 2026)
- ¥230.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026